Dr. Bert Vogelstein, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, discusses results from his analysis of tumor mutation variability, which ultimately suggests that a single tumor biopsy may capture much of the essential information required to inform optimal treatment strategies for those with widespread metastatic cancer. This material relates to a paper that appeared in the Sept. 7, 2018, issue of Science, published by AAAS. The paper, by Johannes Reiter at Stanford University School of Medicine in Palo Alto, CA and colleagues was titled, " Minimal functional driver gene heterogeneity among untreated metastases."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.